Dr. Ravinder Singh, MD

Dr. Singh practices at Southern California Hospital at Hollywood in Hollywood, California, part of Healthcare Systems of America.

Dr. Singh's NPI, 1184648990, was assigned on July 26, 2006. Dr. Singh graduated from St. George's University School of Medicine in 1989. Dr. Singh holds California license A50944.

Dr. Singh's primary practice is Southern California Hospital at Hollywood, at 6245 De Longpre Ave, Hollywood, CA 90028 in Los Angeles County. The practice phone is (323) 462-2271.

Dr. Singh's primary practice is Southern California Hospital at Hollywood in Hollywood, California, part of Healthcare Systems of America. Dr. Singh is also affiliated with Cedars-Sinai Medical Center. The medical group on file is Premier Neurology Medical Group. Dmand AI also links Dr. Singh to 3 more hospitals, 2 group practices and clinics, 1 physician office, 1 home health agency and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Singh practices, 9 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Singh's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Singh is board certified in neurology by the American Board of Psychiatry and Neurology. Dr. Singh is licensed in California.

Dmand AI lists acute mini-stroke (TIA), alzheimer's disease, encephalopathy, epilepsy, fibromyalgia and chronic pain, hereditary polyneuropathy, lower back pain and migraine and chronic headache among the conditions Dr. Singh treats.

CMS data shows 12,170 Medicare services from Dr. Singh across 15 procedure codes in 2024, for 2,093 Medicare patients. Medicare paid $1,018,541 for them.

CMS counts 2,093 Medicare patients who saw Dr. Singh in 2024. The largest group is 65 to 74, with 739 patients. 75% of them have arthritis, and 75% have high blood pressure. 88% are also on Medicaid. Their average risk score is 3.14, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Singh's median patient age at 71, with 48% women.

In 2024, Dr. Singh wrote 3,039 Medicare Part D claims for 299 patients. 84% of them were for generic drugs. CMS names the drug for 2,595 of them, across 73 drugs with 11 or more claims each, at $8,665,014 in total drug cost. In 2023, CMS named 2,516 claims across 78 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Singh for performance year 2024, reported as part of a group. Dr. Singh accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Singh as offering telehealth.

Dmand AI links 2 papers to Dr. Singh, published from 2012 to 2023. Dr. Singh's most frequent co-authors are Judy C. Boughey, MD, Deena Kuruvilla, MD and Valerie Lemaine, MD, MPH.

CMS Open Payments shows 404 general payments to Dr. Singh from 45 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 71% of the total. Eli Lilly and Company paid the most, $35,030.

Dmand AI lists 1 award for Dr. Singh, most recently CMS Stage 1 EHR in 2013.

Dr. Singh graduated from St. George's University School of Medicine in 1989. Dr. Singh is a member of AAN and AHA.

Dr. Singh is in network with 19 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.